Fourth edition of Australasian Leukaemia and Lymphoma Group (ALLG) quarterly newsletter – ALLG News.

The ALLG’s Laboratory Science research is helping determine which patients benefit from targeted therapy for their blood cancer. You can read about this and more in our latest newsletter – ALLG News – that also includes a heart warming story from Brian (featured on the cover) who recently celebrated his 70th birthday thanks to being on a lifesaving ALLG clinical trial 15 years ago for his Chronic Myeloid Leukaemia.

We also feature some of our latest Life Members of the ALLG and a special message from our CEO about our new Clinical Trials Fellowship program, the ALLG’s five decades of impact, and more, in this newsletter.

ALLG News is for people, like you, who are interested in medical research and ALLG’s mission to create better treatments and better lives for patients with blood cancers.

As the only non-profit collaborative clinical trials groups in Australia and New Zealand for blood cancers, the ALLG has the capability to run independent doctor-led clinical trials in Australasia and, crucially, to participate in teletrials and international trials; allowing us access to new treatments, with the potential to make a significant impact on patient outcome.

We hope you enjoy reading about ALLG’s world-leading blood cancer research and the impact your support has for patients with blood cancers. We look forward to sharing more news with you this year, which is the ALLG’s 50th Anniversary year!

You can read ALLG News Edition 4 here and find past editions of ALLG News here.

You can subscribe to future editions of ALLG News here.